Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Zák

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Casopis Lekaru Ceskych|August 18, 2004
[Consequences of moderate hyperhomocysteinemia in internal medicine]A Zák, M Zeman
Casopis Lekaru Ceskych|November 8, 2008
[Atherogenic dyslipidemia and the metabolic syndrome: pathophysiological mechanisms]A Zák, A Slabý
Casopis Lekaru Ceskych|February 9, 2008
[Gene-diet interactions in atherogenic dyslipidemias (part 1)]A Zák, A Slabý
Casopis Lekaru Ceskych|May 13, 2005
[Contemporary prospects of prevention of type 2 diabetes mellitus]M Zeman, A Zák
Casopis Lekaru Ceskych|August 13, 2004
[Pathogenesis and significance of diabetic dyslipidemia]M Zeman, A Zák
Vnitrni Lekarstvi|December 2, 2009
[Therapy of the gastroesophageal reflux disease--state of the art]K Lukás, A Zák
Casopis Lekaru Ceskych|February 25, 2009
[Differential diagnosis of the refractory gastroesophageal reflux diseases]K Lukás, A Zák
Casopis Lekaru Ceskych|July 29, 2010
[On the concept of the metabolic syndrome]A Zák, A Slabý
Casopis Lekaru Ceskych|September 29, 1978
[The metabolic pathway of low-density lipoproteins]A Zák, J Skorepa
Casopis Lekaru Ceskych|September 20, 1995
[Indicators of lipoprotein metabolism in normolipemic men after myocardial infarct]M Zeman, A Zák
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Casopis Lekaru Ceskych|August 18, 2004
[Consequences of moderate hyperhomocysteinemia in internal medicine]A Zák, M Zeman
Casopis Lekaru Ceskych|November 8, 2008
[Atherogenic dyslipidemia and the metabolic syndrome: pathophysiological mechanisms]A Zák, A Slabý
Casopis Lekaru Ceskych|February 9, 2008
[Gene-diet interactions in atherogenic dyslipidemias (part 1)]A Zák, A Slabý
Casopis Lekaru Ceskych|May 13, 2005
[Contemporary prospects of prevention of type 2 diabetes mellitus]M Zeman, A Zák
Casopis Lekaru Ceskych|August 13, 2004
[Pathogenesis and significance of diabetic dyslipidemia]M Zeman, A Zák
Vnitrni Lekarstvi|December 2, 2009
[Therapy of the gastroesophageal reflux disease--state of the art]K Lukás, A Zák
Casopis Lekaru Ceskych|February 25, 2009
[Differential diagnosis of the refractory gastroesophageal reflux diseases]K Lukás, A Zák
Casopis Lekaru Ceskych|July 29, 2010
[On the concept of the metabolic syndrome]A Zák, A Slabý
Casopis Lekaru Ceskych|September 29, 1978
[The metabolic pathway of low-density lipoproteins]A Zák, J Skorepa
Casopis Lekaru Ceskych|September 20, 1995
[Indicators of lipoprotein metabolism in normolipemic men after myocardial infarct]M Zeman, A Zák
Pageof 10